KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) FCF Margin: 2016-2024

Historic FCF Margin for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to 8.70%.

  • Amneal Pharmaceuticals' FCF Margin fell 424.00% to 13.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.01%, marking a year-over-year decrease of 93.00%. This contributed to the annual value of 8.70% for FY2024, which is 393.00% down from last year.
  • According to the latest figures from FY2024, Amneal Pharmaceuticals' FCF Margin is 8.70%, which was down 31.10% from 12.63% recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' FCF Margin ranged from a high of 16.19% in FY2020 and a low of 0.84% during FY2022.
  • In the last 3 years, Amneal Pharmaceuticals' FCF Margin had a median value of 8.70% in 2024 and averaged 7.39%.
  • In the last 5 years, Amneal Pharmaceuticals' FCF Margin skyrocketed by 1,898bps in 2020 and then plummeted by 843bps in 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' FCF Margin (Yearly) stood at 16.19% in 2020, then tumbled by 692bps to 9.27% in 2021, then tumbled by 843bps to 0.84% in 2022, then skyrocketed by 1,179bps to 12.63% in 2023, then slumped by 393bps to 8.70% in 2024.